BDNF and depressive symptom measurement: These findings suggest that BDNF levels are likely to be a biomarker for depression and associated disorders, and support the notion that improvement of symptoms might be associated with the neuroplastic changes achieved by antidepressant treatment (Hashimoto, 2010).